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Abstract
Background: Maternal uniparental disomy (UPD) of chromosome 7 (upd(7)mat) accounts for approximately 10% of
patients with Silver-Russell syndrome (SRS). For upd(7)mat and trisomy 7, a significant number of mechanisms have
been proposed to explain the postzygotic formation of these chromosomal compositions, but all have been based
on as small number of cases. To obtain the ratio of isodisomy and heterodisomy in UPDs (hUPD, iUPD) and to
determine the underlying formation mechanisms, we analysed a large cohort of upd(7)mat patients (n = 73) by
SNP array typing. Based on these data, we discuss the UPDs and their underlying trisomy 7 formation mechanisms.
Results: A whole chromosome 7 maternal iUPD was confirmed in 28.8%, a mixture or complete maternal hUPD in
71.2% of patients.
Conclusions: We could demonstrate that nondisjunction mechanism affecting chromosome 7 are similar to that of
the chromosomes more frequently involved in trisomy (and/or UPD), and that mechanisms other than trisomic
rescue have a lower significance than previously suspected. Furthermore, we suggest SNP array typing for future
parent- and cell-stage-of origin studies in human aneuploidies as they allow the definite classification of trisomies
and UPDs, and provide information on recombinational events and their suggested association with aneuploidy
formation.
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Background
With a frequency of 0.5% among newborns and up to 50%
among abortions, human trisomies significantly contribute
to human malformations and human reproduction failure.
Therefore comprehensive studies have been focused on
the origin and formation mechanisms of human aneu-
ploidies, and their etiological factors. For the common
autosomal trisomies 13, 18 and 21, it has been shown that
they are mainly caused by meiotic errors in oogenesis,
whereas the number of trisomic cases originating from
missegregation in paternal meiosis or postzygotic mitosis
is low [1]. Increased maternal age as well as altered num-
bers and the distribution of recombination sites have been
identified as risk factors for errors in the maternal meiosis
(for review: [2]). Naturally, the majority of data have been
obtained from the frequent human numerical aberrations,
whereas studies on the other chromosomes are hampered
because they are not compatible with live and therefore
only randomly ascertained, e.g. in prenatal diagnosis or in
abortions. As a result, it is difficult to assess whether
general formation mechanisms and factors exist which
contribute to chromosomal nondisjunction and trisomy,
or whether these factors are specific for each chromosome
as suggested by Hassold et al. [1].
With the increasing number of reported cases with
uniparental disomies (UPDs), this ascertainment prob-
lem could at least in part be circumvented for some of
the rare trisomies in particular those which significantly
contribute to the high reproductive failure in humans
and/or can frequently be detected in prenatal testing
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(e.g. chromosomes 7, 16, 20). UPD as the exceptional in-
heritance of both homologues of a chromosomal pair
from the same parent has been reported for nearly every
human chromosome [3]. In case the affected chromo-
some harbors imprinted genes, an imprinting disorder
will arise (e.g Prader-Willi syndrome, Silver-Russell syn-
drome) [4], but for many chromosomes a specific UPD
phenotype does not exist as they do not harbor
imprinted genes. Several mechanisms of UPD formation
have been identified or suggested, with trisomic rescue
as the most important one [5]: here the supernumerary
chromosome of an originally trisomic zygote is lost, a
mechanism which has been confirmed in-vivo (e.g.
[6–9]) (Fig. 1). In contrast, other mechanisms of UPD
formation are conceivable but are rare because they
require a lot of events.
The parental origin and the cell-stage of formation of
trisomy and UPD can be determined by polymorphic
DNA markers consisting of at least two different alleles
(Fig. 1). In case of a normal biparental transmission, an
individual inherits one allele from each parent. In case
of UPD, only alleles from one parent can be observed in
the offspring. In case the contributing parent is hetero-
zygous for two different alleles and both are transferred,
the child has a uniparental heterodisomy (hUPD) for this
marker. In case only one allele is inherited twice, the
offspring is carrier of a uniparental isodisomy (iIUPD).
By considering the physical localization of polymorphic
DNA markers on a chromosome and the type of UPD
(iUPD or hUPD), the stage of meiotic nondisjunction
can be inferred (Fig. 1). In case pericentromeric markers
show hUPD, a meiosis I error is probably the major step
of UPD formation, in case of iUPD for these markers a
meiosis II nondisjunction can be assumed. In contrast, a
iUPD of a whole chromosomes is rather compatible with
a postzygotic mitotic nondisjunction mechanism, for this
constitution three different modes of formation have been






Fig. 1 Formation mechanisms of trisomy and UPD after meiotic and mitotic nondisjunction. iUPD formation by gamete complementation is not
shown as it should be very rare, but the allelic patterns correspond to those of monosomic rescue. Possible typing results of four different
molecular markers are shown to illustrate the role of their physical localization (close or far from the centromere on both arms) for the
discrimination between hUPD and iUPD
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nullisomic by a disomic gamete), (ii) monosomic rescue
(fertilization of a nullisomic by a monosomic gamete with
subsequent endoduplication), and (iii) postfertilization
errors (nondisjunction in a originally disomic zygote result-
ing in a trisomy mosaicism and rescue in a subsequent mi-
tosis, associated with a mosaic constitution) [5].
Until recently, nearly all studies on UPD formation
have been based on microsatellite analyses (short tan-
dem repeat markers, short sequence repeat markers), i.e.
on a group of polymorphic markers consisting of alleles
of different repeat numbers. The high information con-
tent of microsatellite markers and their chromosomal
position allow the delineation of the parental origin of
the supernumerary chromosome as well as determin-
ation of the cell-stage in which the nondisjunction oc-
curs. However, the use of microsatellites is limited by
their number and the incomplete coverage in the gen-
ome. In contrast single nucleotide polymorphisms, des-
pite their limitation to two alleles, have the advantage of
extreme frequency and wide distribution over the hu-
man genome. With the application of SNP array ana-
lysis for molecular karyotyping and the possibility to
differentiate between a homozygosity and heterozy-
gosity as well as uniparental isodisomy and hetero-
disomy, SNP arrays have become a valuable tool to
enlighten the formation mechanisms of trisomies and
UPDs [2, 10].
A relevant UPD in humans is maternal UPD of
chromosome 7 (upd(7)mat), which accounts for approxi-
mately 10% of patients with Silver-Russell syndrome
(SRS, [11]). It has been suggested that a considerable
number of cases are the result from a postzygotically oc-
curring trisomy 7, [1, 12], in that case trisomy 7 would
be different from other autosomal trisomies. To obtain a
representative overview on the ratio of isodisomy and
heterodisomy in UPDs and the underlying formation
mechanisms, we analysed a large cohort of upd(7)mat
individuals by SNP array microsatellite typing. Based on
these data, we discuss their formation mechanism and
that of their underlying trisomy 7.
Study population
Our study cohort was derived from patients who had
been referred for routine testing for Silver-Russell syn-
drome (SRS) to either the French or the German la-
boratories. Some of them have already been reported
[11–16]. Our final cohort consisted of the 76 patients
who were confirmed to have upd(7)mat. In three pa-
tients, a segmental UPD restricted to the long arm had
been reported previously [13, 14]. The others 73 patients
carried a UPD of the whole chromosome 7. Upd(7)mat/
upd(7q)mat was identified molecularly by microsatellite
typing and methylation-specific assays targeting loci on
both arms of chromosome 7.
To compare the distribution of recombination break-
points between the German upd(7)mat carriers and con-
trols, we used data from 28 unrelated German controls
of normal growth.
The study was approved by the ethics review boards of
the University Hospital of the RWTH Aachen and the
Hôpitaux de Paris. Written informed consent for partici-
pation was received for all patients, either from the
patients themselves or their parents.
Methods
Upd(7)mat was identified in the routine diagnostic workup
by methylation-specific tests (methylation-specific (MS)-
PCR, MS single nucleotide primer extension (MS-SNuPE),
MS multiplex ligation probe-dependent amplification
(MS-MLPA), or ASMM RTQ-PCR (TaqMan Allele-Specific
Methylated Multiplex Real-Time Quantitative PCR)),
the upd(7)mat was then confirmed by microsatellite
typing. Further information on the markers used and
PCR conditions are available on request.
From three of the patients with a mixed hUPD/iUPD,
fibroblasts were available and tested by MS-MLPA.
For genome-wide copy number analysis and to deter-
mine the size of isodisomic regions, the patients were
typed by SNP array analysis.
In the 34 German patients, Affymetrix SNP6.0 array
analysis (Affymetrix, Santa Clara, California/USA) was
carried out following the manufacturer’s protocol. Data
analysis was performed with the Genotyping Console
and Chas software (Affymetrix). For iUPD detection, the
software option “LOH” (loss of heterozygosity) was used,
indicating all regions with a loss of heterozygosity
(LOH) (default: >1 kb, >50 marker) (Fig. 2). Chromo-
somal regions were classified as iUPD in case of a LOH,
the non-LOH parts of the chromosomes 7 were de-
fined as hUPD. The number of recombinations was
delineated from the number of hUPD and iUPD
stretches per patient. Furthermore, mosaicism for tri-
somy 7 was determined by SNP array typing, using a
test that had been validated for a mosaic detection
level of 5%.
The 42 patients samples analysed in France were
processed using Infinium assays (HumanCytoSNP-12
or Omniexpress-24BeadChips, Illumina, San Diego,
California/USA) as previously described [17]. Results
were analysed with the Illumina Genome Studiosoft-
ware. For iUPD detection, CNV partition 3.1.6 soft-
ware were used, indicating all regions with a loss of
heterozygosity with a minimum size of 1,000,000 and
a minimum 3 Probe Count.
Results
In the group of 73 carriers of whole chromosome
upd(7)mat tested by SNP array analysis, we determined
Chantot-Bastaraud et al. Molecular Cytogenetics  (2017) 10:28 Page 3 of 7
a complete iUPD in 28.8% (21/73) and a mixture of
complete hUPD or iUPD/hUPD in 71.2% (52/73) of pa-
tients (Table 1). Mean maternal age in the hUPD cohort
(n = 33) was 36.24+/−5.77, in the iUPD group (n = 16) it
was 31.33+/−5.39 years, the difference was statistically
significant (p = 0.006).
SNP array analysis in the three segmental upd(7q)mat
carriers revealed a iUPD for the whole uniparental
regions and confirmed the sizes of the UPD segments
obtained from previous microsatellite studies [13, 14].
The frequency of recombination events was deter-
mined in 20 German hUPD carriers by the Affymetrix
SNP 6.0 array analysis. On average, 9.2 recombinations/
chromosome 7 could be observed per individual, this
frequency did not differ significantly from that in the




Fig. 2 Local Affymetrix GenomeWideSNP_6.0 Array signal distribution pattern (a) showing total upd(7)mat, segmental iUPD(7q)mat and mixed
hUPD/iUPDiUPD. Note that only a differentiation between hUPD and iUPD is possible, whereas the parental origin as well as the identification of
segmental UPD is only possible by including the results of microsatellite typing. b Distribution of SNP (light green) and oligo probes (dark green).
c Physical map of chromosome 7
Table 1 Origin and (postulated) formation mechanisms of the most frequent autosomal trisomies and UPDs. (°only UPD cases with
a definite classification as hUPD or iUPD from [18] are listed)
Chromosome N= Trisomy N= UPD° Reference
Maternal Paternal PZM Maternal Paternal
MI MII MI MII UPhD UPiD UPhD UPiD
2 18 53.4% 13.3% 27.8% 5.6% 11 45.4% 36.4% 9.1% 9.1% Reviewed by [1, 3]
6 18 - 11.1% 88.8% Reviewed by [3]
7 14 27.2% 25.7% 57.1% 55 61.8% 38.2% 4.3% Reviewed by [1, 18]
73 71.2% 28.8% Own data: [11, 12]
8 12 50.0% 50.0% 50.0% 4 50.0% 25.0% 25.0% Reviewed by [1, 3]
13 74 56.6% 33.9% 2.7% 5.4% 1.4% 10 30.0% 20.0% 10.0% 40.0% Reviewed by [1, 3]
14 26 36.5% 36.5% 19.2% 7.7% 48 45.8% 28.8% 10.4% 17.7% Reviewed by [1, 3]
15 34 76.3% 9.0% 14.7% 62 80.6% 6.5% 1.6% 11.3% Reviewed by [1, 8]
16 104 100.0% 35 91.4% 5.7% 2.8% Reviewed by [1, 3]
18 150 33.3% 58.7 8.0% 2 Reviewed by [1, 3]
20 3 2 1 - 5 60.0% 20.0% 20.0% Reviewed by [3]
21 782 69.6% 23.6 1.7% 2.3% 2.7% 12 33.3% 33.3% 33.3% Reviewed by [1, 3]
22 130 86.4% 10.0 1.8% 1.8% 17 52.9% 11.8% 35.3% Reviewed by [1, 3]
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recombination events showed a similar distribution over
the whole chromosome 7 in both cohorts.
In the hUPD cohort, there was no common isodisomic
region but the isodisomic regions were randomly distrib-
uted (Fig. 3).
Array typing in lymphocytes as well as MS-MLPA in
fibroblasts from three out of these cases did not provide
evidence for a trisomy 7/upd(7)mat mosaicism.
As expected, molecular karyotyping revealed several
apathogenic copy number variations, but there was no
evidence for any pathogenic genomic imbalances in this
cohort.
Discussion
Previous reports suggested that in upd(7)mat and trisomy 7
formation postzygotic mitotic nondisjunction plays a sig-
nificant role, accounting for 40 to 57% of cases, respectively
(Table 1), [1, 3, 12, 18, 19] Based on the heterogeneous
findings in trisomies and UPDs of other chromosomes it
has been suggested that three chromosome-specific nondis-
junction mechanisms should exist: a) those accounting for
all chromosomes, b) those affecting a subset of chromo-
somes, and c) those responsible for aneuploidies of single
chromosomes [1]. However, some of these assumptions
were based on single case reports or small cohorts, and a
standardized set of markers covering a whole chromosome
has not been applied. With the present study we can show
for chromosome 7 that the majority of whole chromosome
upd(7)mat cases are hUPD or mixed hUPD/iUPD and thus
originates from maternal meiosis nondisjunction. With a
percentage of ~71%, maternal meiotic errors are the dom-
inant cause of upd(7)mat formation, corresponding to that
of the common autosomal trisomies (Table 1). In fact, this
number is probably higher, as some iUPD might originate
from a meiotic II error without precedent recombination.
Additionally, the major role of maternal meiosis in
upd(7)mat formation is corroborated by the increased ma-
ternal age in the hUPD group in comparison to the iUPD
cohort. Altered numbers and locations of recombination
events as further factor contributing to nondisjunction in
trisomy 21 could not be confirmed for upd(7)mat.
Interestingly, we did not get any evidence for trisomy
7 mosaicism in three hUPD carriers, although the
upd(7)mat formation by trisomic rescue has been proven
directly or indirectly in single studies [6, 7, 12, 20, 21].
In fact, low-level mosaicism can hardly be detected by
SNP array analysis, but we think that trisomy 7 cell lines
should be extremely rare in the body as this constitution
is not compatible with life. The situation seems to be
different in the placenta as the presence of extraem-
bryonic trisomy 7 cells does obviously not affect fetal
growth [22]. As a result, it is obvious that the SRS
phenotype is associated with the upd(7)mat and not with
an undetectable trisomy 7.
Fig. 3 Analysis of the data from the array typing in hUPD carriers: Distribution of uniparental isodisomy stretches in the 20 hUPD cases analysed
by the Affymetrix SNP6.0 arrays
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Trisomic rescue after meiotic nondisjunction is prob-
ably the major mode of upd(7)mat formation in case of
hUPD. However, in case of iUPD the formation mechan-
ism is difficult to determine. At first glance, the reports
on extraembryonic trisomy 7 mosaicism in upd(7)mat
indicate that a postzygotic nondisjunction followed by a
trisomic rescue might have occurred. In that case mosai-
cism for a normal biparental disomic, a trisomic and
iUPD cell line can be expected. As there is no functional
reason for the elimination of the biparental disomic
cells, iUPD should therefore be associated with a mosai-
cism for at least iUPD and normal cells. However, there
is no evidence for a iUPD/biparental cell lines mosai-
cism, we therefore assume that whole iUPD of chromo-
some 7 rather occurs by monosomy rescue than by a
postfertilization error.
In the three carriers of a segmental upd(7q)mat we
could confirm that the uniparental segments were totally
isodisomic. This finding is in agreement with similar
studies on segmental UPDs of chromosomes 6 and 11
representing the major fraction of reported segmental
UPDs in humans [23] (for review: [24, 25]). Interestingly,
mosaicism for segmental UPD can be observed only in
BWS, caused by postzygotic mitotic errors. In case of
segmental upd(6q)mat and upd(7q)mat a mosaic distri-
bution has not yet been reported, it therefore remains
unclear whether they are also caused mitotically or by
meiotic errors.
In our cohort of 73 upd(7)mat carriers we did not
detect any further uniparental (iso)disomies or patho-
genic copy number variations, as reported recently for a
maternal upd(6)mat and a upd(11p)pat carrier [10, 14].
Furthermore, there was no evidence for a common isodi-
somic segment on chromosome 7 in all patients (Fig. 3).
Thus, an autosomal recessive factor on this chromosome
causing SRS can be excluded, and we thereby support the
microsatellite-based data from Preece et al. [26].
Our results confirm the power of SNP array typing to
characterize hUPDs and to determine UPD formation
mechanisms. As Keren et al. [23] recently demonstrated,
SNP array analysis is also a valuable tool to determine
the mosaic distribution of upd(11)pat and partial trisomy
11 cell lines in BWS. However, in case of upd(7)mat mo-
saicism both of UPD and trisomic cell lines is extremely
rare. Therefore for routine diagnosis, it is sufficient to
perform methylation-specific tests and microsatellite
typing.
Conclusions
Our data illustrate the limitations of microsatellite-based
formation studies, thus results based on this type of
markers should be considered with caution as they de-
pend on the distribution of the used markers over the
chromosome. Rather we suggest SNP array typing for
future parent- and cell-stage-of origin studies in human
aneuploidies, because they allow the definite classifica-
tion of trisomies and UPDs. Additionally, they provide
information on recombinational events and their sug-
gested association with aneuploidy formation [2].
Using this approach, we demonstrated that nondis-
junction mechanisms affecting chromosome 7 are simi-
lar to those affecting chromosomes more frequently
involved in trisomy (and/or UPD), and that mechanisms
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